On the dependence of the critical success index (CSI) on prevalence

Gashirai K. Mbizvo, Andrew J. Larner
doi: https://doi.org/10.1101/2023.12.03.23299335

Article Information

doi 
https://doi.org/10.1101/2023.12.03.23299335
History 
  • December 4, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Gashirai K. Mbizvo, NIHR Clinical Lecturer in Neurology1,2,* and
  2. Andrew J. Larner, Consultant Neurologist3
  1. 1Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, United Kingdom
  2. 2Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
  3. 3Cognitive Function Clinic, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
  1. ↵*Correspondence: Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Biosciences Building, Crown Street, Liverpool, L69 7BE, Email: Gashirai.Mbizvo{at}liverpool.ac.uk
Back to top
Posted December 04, 2023.
Download PDF
Data/Code
Email
On the dependence of the critical success index (CSI) on prevalence
Gashirai K. Mbizvo, Andrew J. Larner
medRxiv 2023.12.03.23299335; doi: https://doi.org/10.1101/2023.12.03.23299335
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area